Compare CDTX & AMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDTX | AMG |
|---|---|---|
| Founded | 2012 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 7.6B |
| IPO Year | 2015 | 1997 |
| Metric | CDTX | AMG |
|---|---|---|
| Price | $220.91 | $289.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | $128.75 | ★ $321.00 |
| AVG Volume (30 Days) | ★ 880.9K | 447.3K |
| Earning Date | 11-06-2025 | 02-05-2026 |
| Dividend Yield | N/A | ★ 0.01% |
| EPS Growth | N/A | ★ 6.83 |
| EPS | N/A | ★ 16.71 |
| Revenue | N/A | ★ $2,042,100,000.00 |
| Revenue This Year | N/A | $3.53 |
| Revenue Next Year | N/A | $13.25 |
| P/E Ratio | ★ N/A | $17.26 |
| Revenue Growth | N/A | ★ 1.13 |
| 52 Week Low | $15.22 | $139.22 |
| 52 Week High | $221.20 | $299.69 |
| Indicator | CDTX | AMG |
|---|---|---|
| Relative Strength Index (RSI) | 84.47 | 64.97 |
| Support Level | $220.40 | $286.32 |
| Resistance Level | $221.00 | $299.69 |
| Average True Range (ATR) | 0.47 | 6.30 |
| MACD | -3.46 | 0.46 |
| Stochastic Oscillator | 92.76 | 64.58 |
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
Affiliated Managers Group offers investment strategies to investors through its network of affiliates. The firm typically buys a majority interest in small to mid-size boutique asset managers, receiving a fixed percentage of revenue from these firms in return. Affiliates operate independently, with AMG providing strategic, operational, and technology support, as well as global distribution. At the end of June 2025, AMG's affiliate network—which includes firms like Abacus Capital and Pantheon dedicated to private markets (which accounted for 19% of AUM), AQR Capital and Capula Investment Management in liquid alternatives (24%), and Harding Loevner, Tweedy Browne, Parnassus, and Yacktman in equities, multi-asset, and bond strategies (57%)—had $771 billion in managed assets.